Engineered immune cells take on tough blood cancers in early trial
NCT ID NCT03853616
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 25 times
Summary
This early-stage trial tests a new treatment called MB-CART19.1, which uses a patient's own immune cells that are modified in a lab to better find and attack cancer cells. It is for children and adults with certain blood cancers (like leukemia or lymphoma) that have returned or not responded to standard therapy. The main goal is to find the safest dose and see if the approach is feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL LYMPHOMA REFRACTORY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité - University clinic, pediatric clinic with focus on oncology and hematology
Berlin, 13353, Germany
-
Children's Hospital of Dr. von Hauner by Ludwig-Maximilian University
Munich, 80337, Germany
-
Tuebingen University clinic, medical university clinic for internal medicine
Tübingen, 72076, Germany
-
University clinic for children and youth medicine
Tübingen, 72076, Germany
-
University clinic, pediatric hematology and oncology
Würzburg, 97070, Germany
-
University medicine Goettingen, Clinic of hematology and medical oncology
Göttingen, 37075, Germany
-
Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Universitätsklinikum Münster - Klink für Kinderheilkunde und Jugendmedizin / Pädiatrische Hämatologie und Onkologie
Münster, 48149, Germany
-
Universitätsklinikum Münster - Medizinische Klinik A / KMT Zentrum
Münster, 48149, Germany
Conditions
Explore the condition pages connected to this study.